Technology | Magnetic Resonance Imaging (MRI) | December 06, 2018

Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner

70-cm open bore system with BioMatrix technology expands clinical applications, with in-bore infotainment system and Turbo Suite for faster exams

Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner

December 6, 2018 — During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago, Siemens Healthineers introduced the Magnetom Altea 1.5 Tesla (1.5T) magnetic resonance (MR) scanner, equipped with BioMatrix patient personalization technology.

The Magnetom Altea has a wide, 70-cm bore and BioMatrix technology that includes the Select&Go Interface, powered by artificial intelligence (AI) to enhance workflow productivity. Select&Go removes the need for anatomical landmarking, enabling faster patient positioning. Additionally, the Magnetom Altea is equipped with Tim 4G and Dot (Day Optimizing Throughput) automation that supports standardized, highly reproducible scan procedures. To further facilitate workflow and help ensure patient safety, the system features an optional dockable table.

The Magnetom Altea showcases the new Turbo Suite acceleration packages, a series of customized speed applications for routine examinations of various areas of the body. Turbo Suite can reduce scan time by up to 50 percent without compromising image quality.

To substantially improve patient satisfaction in MR exams, the new MRI scanner also offers as an option the Innovision in-bore infotainment system, designed to travel with the scanner table while immersing the patient in a unique exam experience. In addition to creating the illusion of an enlarged bore, Innovision is designed to provide a video experience with excellent sound quality and display the remaining scan time.

The Magnetom Altea 1.5T MR scanner is available for sale in the U.S.

For more information: www.usa.healthcare.siemens.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Infervision Releases InferTEST Program at SIIM 2019
News | Artificial Intelligence | July 08, 2019
Infervision announced their InferTEST program at the recent Society for Imaging Informatics in Medicine (SIIM)...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Hyland Healthcare Adds ImageNext Imaging Workflow Optimizer to Enterprise Imaging Suite
Technology | Enterprise Imaging | July 05, 2019
Hyland Healthcare is launching ImageNext, a vendor-neutral imaging workflow optimizer that combines intelligent imaging...